Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction

Acta Radiologica

Volumn 38, Issue 4 PART 2, 1997, Pages 732-739

  Grant, Derek ^a   Toft, K G ^a   Martinsen, I ^a   Atzpodien, E ^b  

^a NYCOMED IMAGING AS   (Norway)

^b Nycomed Holdings AS   (Austria)

Author keywords

Biliary obstruction; Contrast media, MR imaging; Experimental; Manganese, MnDPDP; Tissue distribution

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDETIC ACID; MANGANESE; N,N' BIS(PYRIDOXAL 5 PHOSPHATE)ETHYLENEDIAMINE N,N' DIACETIC ACID; N,N'-BIS(PYRIDOXAL-5-PHOSPHATE)ETHYLENEDIAMINE-N,N'-DIACETIC ACID; PYRIDOXAL 5 PHOSPHATE;

ANIMAL; ARTICLE; COMMON BILE DUCT; COMPARATIVE STUDY; DISEASE MODEL; DOG; DRUG SCREENING; LIGATION; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PATHOLOGY; PROGNOSIS; SAFETY; TISSUE DISTRIBUTION;

ANIMALS; CHOLESTASIS, EXTRAHEPATIC; COMMON BILE DUCT; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DOGS; DRUG EVALUATION, PRECLINICAL; EDETIC ACID; LIGATION; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE; PROGNOSIS; PYRIDOXAL PHOSPHATE; SAFETY; TISSUE DISTRIBUTION;

EID: 0031182075     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859709172406     Document Type: Article

References (50)

1. BARRON T. F., DEVENYI A. G. & MAMOURIAN A. C.: Symptomatic manganese neurotoxicity in a patient with chronic liver disease. Correlation of clinical symptoms with MRI findings. Pediatr. Neurol. 10 (1994), 145.
2. BIRD E. D., ANTON A. H. & BULLOCK B.: The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey. Neurotoxicology 5 (1984), 59.
3. CHANDRA S. V., SRIVASTAVA R. S. & SHUKLA G. S.: Regional distribution of metals and biogenic amines in the brain of monkeys exposed to manganese. Toxicol. Lett. 4 (1979), 189.
4. CHUANG J., SHIEH C., CHANG N., CHEN W. & LO S.: Metabolic effect of parenteral nutrition in dogs with obstructive jaundice. J. Am. Coll. Nutr. 14 (1995), 197.
5. COOK D. G., FAHN S. & BRAIT K. A.: Chronic manganese intoxication. Arch. Neurol. 30 (1974), 59.
6. DAVIDSSON L., LONNERDAL B., SANDSTROM B., KUNZ C. & KEEN C. L.: Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 119 (1989), 1461.
7. DEVENYI A. G., BARRON T. F. & MAMOURIAN A. C.: Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome. Gastroenterology 106 (1994), 1068.
8. DRAYER B. P., OLANOW W., BURGER P., JOHNSON R., HERFKENS R. & RIEDERER S.: Parkinson plus syndrome. Diagnosis using high field MR imaging of brain iron. Radiology 159 (1986), 493.
9. EJIMA A., IMAMURA T., NAKAMURA S., SAITO H., MATSUMOTO K. & MOMONO S.: Manganese intoxication during total parenteral nutrition. Lancet 339 (1992), 426.
10. ERIKSSON H., MAGISTE K., PLANTIN L. O. et al.: Effects of manganese oxide on monkeys as revealed by a combined neurochemical, histological and neurophysiological evaluation. Arch. Toxicol. 61 (1987), 46.
11. FELL J. M. E., REYNOLDS A. P., MEADOWS N. et al.: Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347 (1996), 1218.
12. GIBBONS R. A., DIXON S. N., HALLIS K., RUSSELL A. M., SANSOM B. F. & SYMONDS H. W.: Manganese metabolism in cows and goats. Biochim. Biophys. Acta 444 (1976), 1.
13. GRANT D., BLAZAK W. F. & BROWN G. L.: The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 38 (1997), 759.
14. GRANT D., ZECH K. & HOLTZ E.: Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest. Radiol. 29 (1994), S249.
15. HALLS D. J.: Manganese. Chapter 19. In: Trace element analysis in biological specimens, p. 385. Edited by R. F. M. Herber & M. Stoeppler. Elsevier, Amsterdam 1994.
16. HAUSER R. A., ZESIEWICZ T. A., MARTINEZ C., ROSEMURGY A. S. & OLANOW C. W.: Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can. J. Neurol. Sci. 23 (1996), 95.
17. HAUSER R. A., ZESIEWICZ T. A., ROSEMURGY A. S., MARTINEZ C. & OLANOW C. W.: Manganese intoxication and chronic liver failure. Ann. Neurol. 36 (1994), 871.
18. HUANG C. C., CHU N. S., LU C. S. et al.: Chronic manganese intoxication. Arch. Neurol. 46 (1989), 1104.
19. HUSTVEDT S. O., GRANT D., SOUTHON T. E. & ZECH K.: Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 38 (1997), 690.
20. IREGREN A.: Psychological test performance in foundry workers exposed to low levels of manganese. Neurotoxicol. Teratol. 12 (1990), 673.
21. KEEFER R. C., BARAK A. J. & BOYETT J. D.: Binding of manganese and transferrin in rat serum. Biochim. Biophys. Acta 221 (1970), 390.
22. KONTUR P. J. & FECHTER L. D.: Brain regional manganese levels and monoamine metabolism in manganese-treated neonatal rats. Neurotoxicol. Teratol. 10 (1988), 295.
23. KULISEVSKY J., PUJOL J., DEUS J., JUNQUE C., BALANZO J., AVILA A. & CAPDEVILA A.: Persistence of MRI hyperintensity of the globus pallidus in cirrhotic patients. A 2-year follow-up study. Neurology 45 (1995), 995.
24. LARSEN L. E. & GRANT D.: General toxicology of MnDPDP. Acta Radiol. 38 (1997), 770.
25. LEACH R. M. & LILBURN M. S.: Manganese metabolism and its function. World Rev. Nutr. Diet. 32 (1978), 123.
26. LEANDER P.: Liver-specific contrast media for MRI and CT experimental studies. Acta Radiol. 36 (1995), Suppl. 396, p. 1.
27. MIROWITZ S. A., WESTRICH T. J. & HIRSCH J. D.: Hyperintense basal ganglia on T1-weighted MR images in patients receving parenteral nutrition. Radiology 181 (1991), 117.
28. NELSON K., GOLNICK J., KORN T. & ANGLE C.: Manganese encephalopathy. Utility of early magnetic resonance imaging. Br. J. Ind. Med. 50 (1993), 510.
29. NELSON R. C., CHEZMAR J. L., NEWBERRY L. B., MALKO J. A., GEDGAUDAS MCCLEES R. K. & BERNARDINO M. E.: Manganese dipyridoxyl diphosphate. Effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest. Radiol. 26 (1991), 569.
30. NELSON R. C., CHEZMAR J. L., THOMPSON G. H. et al.: Magnetic resonance imaging after arterial portography with manganese dipyridoxal diphosphate. Invest. Radiol. 28 (1993), 335.
31. NEWLAND M. C., CECKLER T. L., KORDOWER J. H. & WEISS B.: Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 106 (1989), 251.
32. NEWLAND M. C. & WEISS B.: Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicol. Appl. Pharmacol. 113 (1992), 87.
33. NI Y., MARCHAL G., YU J. et al.: Experimental liver cancers. Mn-DPDP-enhanced rims in MR-microangiographic-histologic corrrelation study. Radiology 188 (1993), 45.
34. NI Y., MARCHAL G., ZHANG X. et al.: The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization. Invest. Radiol. 28 (1993), 520.
35. 2. Acta Radiol. 38 (1997), 700.
36. POMIER LAYRARGUES G., SPAHR L. & BUTTERWORTH R. F.: Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345 (1995), 735.
37. ROFSKY N. M., WEINREB J. C., BERNARDINO M. E., YOUNG S. W., LEE J. K. & NOZ M. E.: Hepatocellular tumors. Characterization with Mn-DPDP-enhanced MR imaging. Radiology 188 (1993), 53.
38. RUMMENY E., EHRENHEIM C., GEHL H. B. et al.: Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients. Invest. Radiol. 26 Suppl. 1 (1991), S142.
39. RUMMENY E. J., TORRES C. G., KURDZIEL J. C., NILSEN G., OP DE BEECK B. & LUNDBY B.: MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol. 38 (1997), 638.
40. SCHEUHAMMER A. M. & CHERIAN M. G.: The distribution and excretion of manganese. The effects of manganese dose, L-dopa, and pretreatment with zinc. Toxicol. Appl. Pharmacol. 65 (1982), 203.
41. SCHEUHAMMER A. M. & CHERIAN M. G.: Binding of manganese in human and rat plasma. Biochim. Biophys. Acta 840 (1985), 163.
42. TIRKKONEN B., AUKRUST A., COUTURE E. et al.: Physicochemical characterisation of mangafodipir trisodium. Acta Radiol. 38 (1997), 780.
43. TOFT K. G., HUSTVEDT S. O., GRANT D., FRIISK G. A. & SKOTLAND T.: Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Eur. J. Drug Metab. Pharm. 22 (1997), 65.
44. TOFT K. G., HUSTVEDT S. O., GRANT D. et al.: Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 38 (1997), 677.
45. TOFT K. G., KINDBERG G. M. & SKOTLAND T.: Mangafodipir . trisodium injection, a new contrast medium for magnetic resonance imaging. In vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharm. Biomed. Anal. 15 (1997), 983.
46. TORRES C. G., LUNDBY B., TUFTE STERUD A., MCGILL S., GORDON P. B. & STRAND BJERKNES H.: MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol. 38 (1997), 631.
47. WANG C., GORDON P. B., HUSTVEDT S. O. et al.: MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 38 (1997), 665.
48. WANG J. D., HUANG C. C., HWANG Y. H., CHIANG J. R., LIN J. M. & CHEN J. S.: Manganese induced parkinsonism. An outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br. J. Ind. Med. 46 (1989), 856.
49. WEISSENBORN K., EHRENHEIM C., HORI A., KUBICKA S. & MANNS M. P.: Pallidal lesions in patients with liver cirrhosis. Clinical and MRI evaluation. Metab. Brain Dis. 10 (1995), 219.
50. YAMADA M., OHNO S., OKAYASU I. et al.: Chronic manganese poisoning. A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol. Berl. 70 (1986), 273.